Navigation Links
Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
Date:3/30/2009

ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Frederick, MD (PRWEB) March 30, 2009 -- ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Ms. DiCarlo most recently served as the Dermatology Clinical Development Manager for NitricBio Therapeutics, Inc., an early stage biotechnology company where she led dermatology product development, and topical infectious disease drug/device development, and clinical trial programs all of which she managed through the identification and implementation of a customized platform of electronic clinical trial management applications.

Additionally, Ms. DiCarlo has utilized her extensive operational technology & regulatory expertise to combine intelligent electronic technology systems integration to develop and map operational and workflow processes to successfully support the launch several full service eCRO's, eIRB's, eSMO's, eResearch consortiums, and dedicated clinical research sites.

"I am passionate about actively contributing clinical research and development initiatives through the development, integration, adoption and implementation of intelligent technology applications to efficiently support clinical operations, and clinical research & development initiatives," said DiCarlo.

"My experience in deploying efficient real-time electronic applications to manage clinical trials leads me to believe that both industry and regulatory authorities will embrace the adoption and use of electronic clinical trial informed consenting practices."

We are pleased that Ms DiCarlo has joined us, says Susan Brink, DrPH, Chairman of the Board. Her track successful track record of applying technology solutions to support clinical trials, along with her business development acumen, EDC/CTMS, IRB, subject recruitment organizations, and CRO industry contacts position her to well to form technology business to business partnerships that will create added value for ConsentSolutions, Inc.

About ConsentSolutions, Inc
Founded in 2005, headquartered in Frederick, Maryland, with offices in Gaithersburg, ConsentSolutions is focused on adding value to the consenting process through the development of interactive, user-friendly educational software to effectively deliver clinical trial information electronically allowing study candidates to make important decisions about clinical trial participation. With decades of combined experience developing educational multimedia applications, ConsentSolutions, Inc. senior management team is dedicated to the goal of shared decision making for trial participation among study candidates, clinical trial coordinators, investigators, and physicians.

For more information contact:

Jovianna DiCarlo, President & CEO
jdicarlo (at) consentsolutions (dot) com
240-575-1918 Ext. 261
267.884.3456
www.consentsolutions.com

# # #

Read the full story at http://www.prweb.com/releases/2009/03/prweb2270884.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
2. US Oncology Named to FORTUNE Magazines Most Admired Companies List for Third Time
3. Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
4. Zymetis Inc. Named Top 50 Cleantech/Greentech Company
5. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
6. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
7. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
8. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
9. Kendle Named a Best Place to Work in Greater Cincinnati
10. Sinovac Named to Deloitte Technology Fast 50 China
11. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... CA (PRWEB) , ... August 15, 2017 , ... ... pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of ... number of steps needed to gain kinetic binding data for a wide range ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum ... 360° (IO360°) programming through a series of upcoming panels and events. The partnership culminates ... at The Roosevelt Hotel in New York City. , “With our experience in producing ...
(Date:8/14/2017)... ... August 14, 2017 , ... Opal ... using USB or PCI Express, announced the release of SYZYGY™, a new open ... satisfy the need for a compact, low cost, low pin-count, high-performance connectivity solution ...
(Date:8/11/2017)... ... August 11, 2017 , ... Algenist continues to disrupt ... unlocking collagen like never before. , Collagen is the key structural element skin ... with Liquid Collagen™, which include: , First to market ...
Breaking Biology Technology:
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):